German company BioNTech and its US partner Pfizer announced on Monday that early results from ongoing Phase III trials showed that their vaccine was 90% effective in preventing COVID-19 infections. The statement from the two companies is the first release of successful data from a large-scale trial of coronavirus vaccines
Monday, November 9, 2020
German company BioNTech and Pfizer announce 90% effictive coronavirus vaccine
German company BioNTech and its US partner Pfizer announced on Monday that early results from ongoing Phase III trials showed that their vaccine was 90% effective in preventing COVID-19 infections. The statement from the two companies is the first release of successful data from a large-scale trial of coronavirus vaccines
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment